Filter
1076
Filtered Results: 1076
Text search:
Department
of
Health
Philippines
Featured
Recommendations
103
New Publications
300
Language
Document type
No document type
618
Studies & Reports
198
Guidelines
114
Manuals
63
Training Material
30
Strategic & Response Plan
28
Fact sheets
10
Situation Updates
8
Resource Platforms
4
Infographics
2
Brochures
1
Countries / Regions
Philippines
112
Global
72
Myanmar / Burma
35
Asia
27
South–East Asia Region
18
India
17
Nepal
14
Western Pacific Region
14
Bangladesh
12
Indonesia
10
South Africa
10
Africa
9
Nigeria
8
Ethiopia
8
Thailand
8
Latin America and the Carribbean
8
Sierra Leone
7
Liberia
7
Kenya
7
Western and Central Europe
7
Cambodia
6
Vietnam
6
Guinea
5
Tanzania
5
China
5
Brazil
5
Colombia
5
Pakistan
4
South Sudan
4
Syria
4
Rwanda
4
Mozambique
4
Papua New Guinea
4
Yemen
4
Uganda
3
Haiti
3
Afghanistan
3
Ukraine
3
Ecuador
3
Sri Lanka
3
Laos
3
Japan
3
Burkina Faso
2
Senegal
2
Congo, Democratic Republic of
2
Ghana
2
Somalia
2
Iraq
2
Jordan
2
Malaysia
2
Sudan
2
Central African Republic
2
Angola
2
West and Central Africa
2
Venezuela
2
Eastern Europe
2
Palestine
2
Mongolia
2
Mali
1
Guinea-Bissau
1
USA
1
Cameroon
1
Niger
1
Lebanon
1
Zambia
1
Turkey
1
Malawi
1
Namibia
1
Botswana
1
Libya
1
Lesotho
1
Mexico
1
East and Southern Africa
1
Middle East and North Africa
1
Other region
1
Bhutan
1
Italy
1
Timor Leste/ East Timor
1
Estonia
1
Moldova
1
Iran
1
Spain
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
245
Clinical Guidelines
120
Public Health
85
Key Resources
84
Women & Child Health
72
Capacity Building
19
Pharmacy & Technologies
17
Toolboxes
Mental Health
104
Disability
85
HIV
76
TB
75
COVID-19
53
Planetary Health
46
Natural Hazards
40
Rapid Response
36
NTDs
33
Global Health Education
30
Caregiver
30
AMR
24
NCDs
23
Pharmacy
21
Ebola
20
Conflict
18
Refugee
16
Health Financing Toolbox
16
Polio
8
Cholera
7
Specific Hazards
3
Typhoon
2
Zika
2
Social Ethics
2
13 May 2021
To avoid a reversal of progress from the adverse impacts of the COVID-19 pandemic, new knowledge and lessons from successful programmatic innovations are urgently needed to improve TB p...
Against this background of nearly 20 years of experience of research, development and
improvement in patient safety, the role ... incident and adverse event reporting, as well as the
benefits that derive from it, is still a work in progress.This document has two main purposes:
• to provide an up-to-date perspective on patient safety incident reporting and
learning systems currently in place, including how to fill in existing gaps in these
systems;
• to provide practical guidance on the establishment and effective use of patient
safety incident reporting and learning systems.
This report presents country, regional and global estimates of low birth weight for 2000, together with a detailed description of the methods used in calculating the estimates. Some limited data on ...
Addressing comorbidities and risk factors for TB is a crucial component of Pillar one of the End TB Strategy, which focuses on integrated patient-centred care and prevention, including action on TB ...
This document is an output of a WHO cross-programme initiative aiming to improve the prevention, diagnosis and management of anaemia and thereby accelerate reduction in its prevalence. It comes at a...
This manual is designed primarily to assist managers of national malaria programmes and national reference laboratory responsible for quality assurance of malaria microscopy control. The information...
Preventive chemotherapy to control soil-transmitted helminth infections in at-risk population groups
recommended
Treating children infected with intestinal worms is one of the simplest and most cost–effective ways to improve their health.
The recommendations are intended for a wide audience, including poli...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Developmen...
Traditional medicine, including the knowledge, skills and practices of holistic health care, exists in all cultures. It is based on indigenous theories, beliefs and experiences and is widely accepte...
WHO/ESCAP Training Manual on Disability Statistics | This training manual intends to enhance the understanding of the ICF-based approach to disability measurement. It provides an overview of the IC...
The 2023 Country Presence Report provides an overview of what WHO does in countries to advance towards the SDGs and implement GPW13, how we do it, with whom we work, and what is needed to overcome challenges for achieving results and impact in count...
A framework for action provides a guide for those involved in the development of the multisectoral action plan. It starts with a wide-ranging vision and, through a series of increasingly specific in...
The Committee examined the clinical development of Ebola virus vaccines and conducted an inventory of available data on their safety. It also reviewed 3 generic issue...
A Global Inventory of Alternative Medical Waste Treatment Technologies
There is a substantial and ever-increasing unmet need for rehabilitation worldwide, which is particularly profound in low- and middle
-income countries. The availability of accessible and affordable rehabilitation is necessary for many people with ...
national programmes for occupational health and safety for health workers: lessons learned from countries: summary report of the WHO online worksho...
Guideline ‒ Alternative mass drug administration regimens to eliminate lymphatic filariasis
recommended
Lymphatic filariasis is a vector-borne neglected tropical disease that causes damage of the lymphatic system and can lead to lymphoedema (elephantiasis) and hydrocele in infected individuals. The global baseline estimate ... persons affected by lymphatic filariasis is 25 million men with hydrocele and over 15 million people with lymphoedema. At least 36 million persons remain with these chronic disease manifestations. The disease is endemic in 72 countries. In 2016, an estimated total population of 856 million were living in areas with ongoing transmission of the causative filarial parasites and requiring mass drug administration (MDA). Lymphatic filariasis disfigures and disables, and often leads to stigmatization and poverty. Hundreds of millions of dollars are lost annually due to reduced productivity of affected patients. WHO has ranked the disease as one of the world’s leading causes of permanent and long-term disability.
The plan contains the latest available evidence on the extent of insecticide resistance around the world, and puts forward a strategy for global and country levels, identifying clear roles and timelines for all stakeholders. The GPIRM also summarize...
Policy Note #4: Myanmar Health Systems in Transition Policy Notes Series
Protecting people from financial hardship when they fall ill is one of the two key elements ... universal health coverage (UHC). In practice, this means that the majority of health care costs have to be met from government revenues so that services are provided free or with a small affordable co-payment. The alternative is to rely on pre-payment through some form of insurance, where risks are pooled across all contributors.
The challenge in Myanmar is that at present neither approach is functioning. Government spending is too low to meet people’s health needs and the proportion of the population covered by insurance is negligible. As a result, families face a stark choice in the event of serious illness: either defer treatment and face the consequences, or incur what can amount to catastrophic expenses and a downward spiral of disinvestment and poverty.
Protecting people from financial hardship when they fall ill is one of the two key elements ... universal health coverage (UHC). In practice, this means that the majority of health care costs have to be met from government revenues so that services are provided free or with a small affordable co-payment. The alternative is to rely on pre-payment through some form of insurance, where risks are pooled across all contributors.
The challenge in Myanmar is that at present neither approach is functioning. Government spending is too low to meet people’s health needs and the proportion of the population covered by insurance is negligible. As a result, families face a stark choice in the event of serious illness: either defer treatment and face the consequences, or incur what can amount to catastrophic expenses and a downward spiral of disinvestment and poverty.
Antimicrobial resistance (AMR) is a serious public health concern with economic, social and political implications that are global in scope, and cross all environmental and ethnic boundaries. As a global threat, AMR risks the ach...
